fluoxetine has been researched along with Cerebral Hemorrhage in 2 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
Cerebral Hemorrhage: Bleeding into one or both CEREBRAL HEMISPHERES including the BASAL GANGLIA and the CEREBRAL CORTEX. It is often associated with HYPERTENSION and CRANIOCEREBRAL TRAUMA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Spontaneous, nontraumatic intracerebral hemorrhage (ICH) is a subtype of stroke that causes a great amount of disability and economic and social burden." | 6.78 | Fluoxetine for motor recovery after acute intracerebral hemorrhage (FMRICH): study protocol for a randomized, double-blind, placebo-controlled, multicenter trial. ( Aguayo-Leytte, G; Arauz, A; Cruz-Estrada, Ede L; Huerta-Franco, MR; Marquez-Romero, JM; Ruiz-Franco, A; Ruiz-Sandoval, JL; Silos, H, 2013) |
| "Spontaneous, nontraumatic intracerebral hemorrhage (ICH) is a subtype of stroke that causes a great amount of disability and economic and social burden." | 2.78 | Fluoxetine for motor recovery after acute intracerebral hemorrhage (FMRICH): study protocol for a randomized, double-blind, placebo-controlled, multicenter trial. ( Aguayo-Leytte, G; Arauz, A; Cruz-Estrada, Ede L; Huerta-Franco, MR; Marquez-Romero, JM; Ruiz-Franco, A; Ruiz-Sandoval, JL; Silos, H, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Marquez-Romero, JM | 1 |
| Arauz, A | 1 |
| Ruiz-Sandoval, JL | 1 |
| Cruz-Estrada, Ede L | 1 |
| Huerta-Franco, MR | 1 |
| Aguayo-Leytte, G | 1 |
| Ruiz-Franco, A | 1 |
| Silos, H | 1 |
| He, W | 1 |
| Cai, D | 1 |
| Lin, L | 1 |
| Fang, Y | 1 |
| Zheng, X | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Fluoxetine for Motor Recovery After Acute Intracerebral Hemorrhage (FMRICH): a Randomised Placebo-controlled Trial[NCT01737541] | Phase 3 | 32 participants (Actual) | Interventional | 2012-11-30 | Terminated (stopped due to Study recruitment was suspended due to lack of funding) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for fluoxetine and Cerebral Hemorrhage
| Article | Year |
|---|---|
Fluoxetine for motor recovery after acute intracerebral hemorrhage (FMRICH): study protocol for a randomized, double-blind, placebo-controlled, multicenter trial.
Topics: Cerebral Hemorrhage; Clinical Protocols; Disability Evaluation; Double-Blind Method; Female; Fluoxet | 2013 |
Clinical studies on event-related potentials (ERPs) N400 and the related factors in patients with poststroke depression (PSD).
Topics: Aged; Antidepressive Agents, Second-Generation; Blood Platelets; Cerebral Hemorrhage; Cerebral Infar | 2010 |